Case report reveals management complexities of portal vein thrombosis in cirrhotic patients, highlighting individualized care.
Portal vein thrombosis is a common complication in cirrhosis, especially in patients with decompensated disease, associated hepatocellular carcinoma, or those awaiting liver transplantation. Anticoagulation is the first-line therapy to improve transplant feasibility and outcomes in this context, although bleeding risk, particularly in the presence of portal hypertension, adds a notable challenge and complexity to its management. We report the case of a patient with cirrhosis who presented with gastrointestinal bleeding due to gastroesophageal variceal rupture and hepatic encephalopathy, complicated by porto-mesenteric thrombosis. While undergoing pre-liver transplantation workup and shortly following the beginning of anticoagulation, he developed a subdural hematoma, highlighting the complexity of risk-benefit assessment and therapeutic decision-making. Thus, this case report highlights the delicate balance between haemorrhagic risk and thrombotic benefit and supports individualized, multidisciplinary management of PVT in cirrhotic patients.
No takes yet. Share an insight, caveat, or question.
Almeida et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: